Caplight Logo









Nuvaira

Nuvaira

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://www.nuvaira.com

Last Round

Early Stage

VC

Mar 4, 2026

Total Funding Raised

$140.22M

Company Overview

Nuvaira is a medical technology company that develops a novel catheter-based device aimed at improving outcomes for patients with obstructive lung diseases by treating overactive airway nerves.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

targeted lung denervationTLDCOPD treatmentlung denervationmedical deviceradiofrequency ablationMedTechinterventional pulmonologyRF ablationbronchoscopic procedureobstructive lung diseasedisposable catheterminimally invasive therapyasthma treatmentrazor and blade modelCE Mark

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuvaira Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nuvaira Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMar 4, 2026
SeedAug 25, 2025
VC RoundNov 28, 2023
Series EFeb 11, 2019
Series DApr 3, 2014
Series C
Feb 11, 2013

Nuvaira Investors

Notable investors and investment history

InvestorRounds
Vertex Ventures HCSeries E
Lightstone VenturesSeries E
Split Rock PartnersSeries C, Series A, Series D, Series E
U.S. Venture PartnersSeries E
Richard King Mellon FoundationSeries E
Versant VenturesSeries C, Series A, Series D, Series E
Advanced Technology VenturesSeries C, Series A, Series D, Series E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Raised $36M in an early stage VC round.

Nuvaira Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nuvaira Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nuvaira's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range21
Year Founded2008
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.